CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 523 enrolled
Drug / intervention
infusion of 2 units of plasmabiological
Likely dose
infusion of 2 units of plasmafrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01818427
NCT01818427Phase 3Completed
CompareCT.gov

Prehospital Air Medical Plasma (PAMPer) Phase III Multicenter, Prospective, Randomized, Open-label, Interventional Trial A Four Year Multicenter Open Label Randomized Trial

Jason Sperry·interventional·Posted Mar 26, 2013·Updated Apr 8, 2021

In Brief

A Phase 3 clinical trial evaluating infusion of 2 units of plasma for Hemmorhagic Shock During Air Medical Transport. Completed, enrolled 523 participants across 1 site.

Detailed Summary

To determine the effect of the prehospital infusion during air transport of 2 units of AB plasma on 30 day mortality in patients with hemorrhagic shock as compared to conventional care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHemmorhagic Shock During Air Medical Transport
CountriesUnited States
CollaboratorsUniversity of Texas, University of Louisville, Vanderbilt University, Case Western Reserve University, The University of Tennessee, Knoxville, JPS Health Network, The Methodist Hospital Research Institute

Timeline

Phase 3CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedMar 26, 2013
Enrollment StartMay 1, 2014
Primary CompletionSep 1, 2017
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.3 years ago

Interventions

infusion of 2 units of plasmabiological

infusion of 2 units of plasma